News 05. März 2024 Immunocore turns to Oncobit platform The British biotechnology company Immunocore will in future make use of the platform developed by Oncobit, a medtech firm and spin-off from the U...
Aktuell 05. März 2024 Immunocore setzt auf Plattform von Oncobit Die britische Biotech-Firma Immunocore nutzt in Zukunft die Plattform des Medtech-Unternehmens Oncobit, einer Ausgliederung der Universität Züric...
News 26. März 2024 Top Stories from Western Switzerland (March 2024) From innovative approaches in cardiac care and sustainable plastics to enhancing spinal cord injury therapies and advancing virtual power plants,...
Aktuell 22. Jan. 2024 DISCO Pharmaceuticals startet mit 20 Millionen Euro Kapital DISCO Pharmaceuticals ist mit einem Startkapital von 20 Millionen Euro neu auf dem Markt. Sein Team hat als erstes eine Methode entwickelt, die e...
News 31. Okt. 2023 Debiopharm invests CHF 30 million in Valais amidst workforce surge Debiopharm Research & Manufacturing has announced an investment of over CHF 30 million in a Martigny lab expansion as staff numbers rise from 150...
News 04. Apr. 2024 Indivi joins forces with Biogen Indivi and Biogen are cooperating on the development of digital biomarkers for Parkinson’s disease. To this end, the US biotech group is licensin...
Actualités 17. Apr. 2024 Addex Therapeutics lance la spin-off Neurosterix à Genève avec un investissement de USD 63 millions La société genevoise Addex Therapeutics s’est associée à Perceptive Advisors pour lancer la spin-off Neurosterix, un nouvel acteur dans le dévelo...
News 13. Juni 2023 Merck unveils its cutting-edge Biotech Development Center in Corsier-sur-Vevey German pharmaceutical giant Merck has celebrated the inauguration of its state-of-the-art Biotech Development Center in Corsier-sur-Vevey.
News 19. Dez. 2023 Top Stories from Western Switzerland (October-December 2023) From achieving top rankings in global innovation to making significant advancements in healthcare and technology, discover Western Switzerland's ...
News 31. Juli 2023 InSphero announces an award for 3D in vitro models InSphero, based in the canton of Zurich, and the Physicians Committee for Responsible Medicine have launched a joint award program. Five academic...
News 14. März 2024 Bühler and Icos join forces to promote start-ups The Bühler Group and Icos Capital have agreed a partnership with the aim of networking start-ups active in the fields of chemicals and biotechnol...
Actualités 26. März 2024 Les Grands Titres de Suisse occidentale (Mars 2024) D’approches innovantes en matière de soins cardiaques et de plastiques durables à l’amélioration des thérapies pour les lésions de la moelle épin...
News 03. Nov. 2023 EPFL and Novochizol to collaborate on designing more efficient immunotherapies A groundbreaking collaboration between EPFL's Laboratory of Biomaterials for Immunoengineering and Novochizol aims to revolutionize cancer treatm...
News 29. Febr. 2024 Top Stories from Western Switzerland (February 2024) From significant strides in semiconductor innovation and breakthroughs in medical research to strategic advancements in fintech and medtech secto...
News 13. Dez. 2023 Macrogen establishes foothold in Basel Macrogen Europe is set to move into the Novartis Campus of Switzerland Innovation Park Basel Area. As with its parent company, the South Korean b...
Aktuell 31. Juli 2023 InSphero lobt Preis für 3D-In-vitro-Modelle aus InSphero und das Physicians Committee for Responsible Medicine starten gemeinsam ein Award-Programm. Dabei werden fünf akademische Teams mit 3D-M...
Actualités 06. Okt. 2022 Le Biopôle grandit encore avec la construction de trois nouveaux bâtiments Biopôle a annoncé que la SICAV Edmond de Rothschild Real Estate investira dans la construction de trois nouveaux bâtiments sur le campus d’Epalin...